(Q46899663)

26 December 2017

title

Population variation in VKORC1 haplotype structure (English)

1 reference

26 December 2017

author name string

S Marsh

1

1 reference

26 December 2017

C R King

2

1 reference

26 December 2017

R M Porche-Sorbet

3

1 reference

26 December 2017

T J Scott-Horton

4

1 reference

26 December 2017

C S Eby

5

1 reference

26 December 2017

publication date

1 February 2006

1 reference

26 December 2017

Journal of Thrombosis and Haemostasis

published in

1 reference

26 December 2017

volume

4

1 reference

26 December 2017

issue

2

1 reference

26 December 2017

page(s)

473-474

1 reference

26 December 2017

Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01759.X

A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01759.X

The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: proposal for a new dosing regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01759.X

Association of pharmacokinetic (CYP2C9) and pharmacodynamic (factors II, VII, IX, and X; proteins S and C; and gamma-glutamyl carboxylase) gene variants with warfarin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01759.X

The influence of ethnicity on warfarin dosage requirement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01759.X

10.1111/J.1538-7836.2006.01759.X

21 January 2018

Identifiers

DOI

1 reference

26 December 2017

1 reference

26 December 2017